Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero) phosphate-rich membranes at acidic pH: Unglycosylated patient variant saposin B lacks lipid-extraction capacity

FEBS Journal

Volumn 274, Issue 13, 2007, Pages 3405-3420

  Remmel, Natascha ^a   Locatelli Hoops, Silvia ^a   Breiden, Bernadette ^a   Schwarzmann, Guenter ^a   Sandhoff, Konrad ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Glycosphingolipid; Lipid binding protein; Lysosome; Sap; Saposin

Indexed keywords

ASPARTIC ACID; BIS(MONOACYLGLYCERO)PHOSPHATE; CHOLESTEROL; GLYCOSPHINGOLIPID; HISTIDINE; LIPID; LIPID BINDING PROTEIN; LIPOSOME; PHOSPHORUS DERIVATIVE; RECOMBINANT PROTEIN; SAPOSIN B; SPHINGOLIPID ACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; LIPID MEMBRANE; LIPID METABOLISM; LIPIDOSIS; LYSOSOME; MEMBRANE STRUCTURE; NONHUMAN; PH; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; SURFACE PLASMON RESONANCE;

CELL MEMBRANE; CHOLESTEROL; CLONING, MOLECULAR; GLYCOSYLATION; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; LIPOSOMES; LYSOPHOSPHOLIPIDS; LYSOSOMES; MODELS, BIOLOGICAL; MONOGLYCERIDES; OLIGOSACCHARIDES; PICHIA; SAPOSINS; SURFACE PLASMON RESONANCE;

PICHIA PASTORIS;

EID: 34347405277     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05873.x     Document Type: Article

References (72)

1. Kolter T Sandhoff K (2005) Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 21, 81 103.
2. Eskelinen EL, Tanaka Y Saftig P (2003) At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13, 137 145.
3. Peters C von Figura K (1994) Biogenesis of lysosomal membranes. FEBS Lett 346, 108 114.
4. Bradova V, Smid F, Ulrich-Bott B, Roggendorf W, Paton BC Harzer K (1993) Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum Genet 92, 143 152.
5. Giehl A, Lemm T, Bartelsen O, Sandhoff K Blume A (1999) Interaction of the GM2-activator protein with phospholipids-ganglioside bilayer membranes and with monolayers at the air-water interface. Eur J Biochem 261, 650 658.
6. Möbius W, van Donselaar E, Ohno-Iwashita Y, Shimada Y, Heijnen HF, Slot JW Geuze HJ (2003) Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 4, 222 231.
7. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG Gruenberg J (1998) A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392, 193 197.
8. Vogel A, Schwarzmann G Sandhoff K (1991) Glycosphingolipid specificity of the human sulfatide activator protein. Eur J Biochem 200, 591 597.
9. Conzelmann E, Burg J, Stephan G Sandhoff K (1982) Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Eur J Biochem 123, 455 464.
10. Fischer G Jatzkewitz H (1978) The activator of cerebroside-sulphatase. A model of the activation. Biochim Biophys Acta 528, 69 76.
11. Hiraiwa M, Soeda S, Martin BM, Fluharty AL, Hirabayashi Y, O'Brien JS Kishimoto Y (1993) The effect of carbohydrate removal on stability and activity of saposin B. Arch Biochem Biophys 303, 326 331.
12. Fluharty CB, Johnson J, Whitelegge J, Faull KF Fluharty AL (2001) Comparative lipid binding study on the cerebroside sulfate activator (saposin B). J Neurosci Res 63, 82 89.
13. Ciaffoni F, Tatti M, Boe A, Salvioli R, Fluharty A, Sonnino S Vaccaro AM (2006) Saposin B binds and transfers phospholipids. J Lipid Res 47, 1045 1053.
14. Wendeler M, Werth N, Maier T, Schwarzmann G, Kolter T, Schoeniger M, Hoffmann D, Lemm T, Saenger W Sandhoff K (2006) The enzyme-binding region of human GM2-activator protein. FEBS J 273, 982 991.
15. Zhou D, Cantu 3rd C, Sagiv Y, Schrantz N, Kulkarni AB, Qi X, Mahuran DJ, Morales CR, Grabowski GA, Benlagha K et al. (2004) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303, 523 527.
16. Zhou D, Mattner J, Cantu 3rd C, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786 1789.
17. Bruhn H (2005) A short guided tour through functional and structural features of saposin-like proteins. Biochem J 389, 249 257.
18. Munford RS, Sheppard PO O'Hara PJ (1995) Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J Lipid Res 36, 1653 1663.
19. Vaccaro AM, Salvioli R, Tatti M Ciaffoni F (1999) Saposins and their interaction with lipids. Neurochem Res 24, 307 314.
20. Kolter T, Winau F, Schaible UE, Leippe M Sandhoff K (2005) Lipid-binding proteins in membrane digestion, antigen presentation, and antimicrobial defense. J Biol Chem 280, 41125 41128.
21. Ahn VE, Faull KF, Whitelegge JP, Fluharty AL Prive GG (2003) Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc Natl Acad Sci USA 100, 38 43.
22. Ahn VE, Leyko P, Alattia JR, Chen L Prive GG (2006) Crystal structures of saposins A and C. Protein Sci 15, 1849 1857.
23. Schnabel D, Schröder M, Fürst W, Klein A, Hurwitz R, Zenk T, Weber J, Harzer K, Paton BC, Poulos A et al. (1992) Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J Biol Chem 267, 3312 3315.
24. Hulkova H, Cervenkova M, Ledvinova J, Tochackova M, Hrebicek M, Poupetova H, Befekadu A, Berna L, Paton BC, Harzer K et al. (2001) A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 10, 927 940.
25. Elleder M, Jerabkova M, Befekadu A, Hrebicek M, Berna L, Ledvinova J, Hulkova H, Rosewich H, Schymik N, Paton BC et al. (2005) Prosaposin deficiency - a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. Neuropediatrics 36, 171 180.
26. Fujita N, Suzuki K, Vanier MT, Popko B, Maeda N, Klein A, Henseler M, Sandhoff K Nakayasu H (1996) Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and widespread storage of multiple sphingolipids. Hum Mol Genet 5, 711 725.
27. Burkhardt JK, Hüttler S, Klein A, Möbius W, Habermann A, Griffiths G Sandhoff K (1997) Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. Eur J Cell Biol 73, 10 18.
28. Gärtner S, Conzelmann E Sandhoff K (1983) Activator protein for the degradation of globotriaosylceramide by human alpha-galactosidase. J Biol Chem 258, 12378 12385.
29. Fischer G, Reiter S Jatzkewitz H (1978) Enzymic hydrolysis of sulphosphingolipids and sulphoglycerolipids by sulphatase A in the presence and absence of activator protein. Hoppe Seylers Z Physiol Chem 359, 863 866.
30. Whitelegge JP, Ahn V, Norris AJ, Sung H, Waring A, Stevens RL, Fluharty CB, Prive G, Faull KF Fluharty AL (2003) Characterization of a recombinant molecule covalently indistinguishable from human cerebroside-sulfate activator protein (CSAct or Saposin B). Cell Mol Biol (Noisy-le-Grand) 49, 799 807.
31. Wrobe D, Henseler M, Huettler S, Pascual Pascual SI, Chabas A Sandhoff K (2000) A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). J Inherit Metab Dis 23, 63 76.
32. Zhang XL, Rafi MA, DeGala G Wenger DA (1991) The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum Genet 87, 211 215.
33. Holtschmidt H, Sandhoff K, Kwon HY, Harzer K, Nakano T Suzuki K (1991) Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem 266, 7556 7560.
34. Regis S, Filocamo M, Corsolini F, Caroli F, Keulemans JL, van Diggelen OP Gatti R (1999) An Asn ? Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity. Eur J Hum Genet 7, 125 130.
35. Kretz KA, Carson GS, Morimoto S, Kishimoto Y, Fluharty AL O'Brien JS (1990) Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Proc Natl Acad Sci USA 87, 2541 2544.
36. Sandhoff K, Kolter T Harzer K (2001) Shingolipid activator proteins. In The Metabolic and Molecular Bases of Inherited Disease (Scriver CR, Beaudet AL, Sly WS Valle D, eds), Vol. 3, pp. 3371 3388. McGraw-Hill, New York.
37. Wendeler M, Hoernschemeyer J, John M, Werth N, Schoeniger M, Lemm T, Hartmann R, Kessler H Sandhoff K (2004) Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization. Protein Expr Purif 34, 147 157.
38. Yamada M, Inui K, Hamada D, Nakahira K, Yanagihara K, Sakai N, Nishigaki T, Ozono K Yanagihara I (2004) Analysis of recombinant human saposin A expressed by Pichia pastoris. Biochem Biophys Res Commun 318, 588 593.
39. Locatelli-Hoops S, Remmel N, Klingenstein R, Breiden B, Rossocha M, Schoeniger M, Koenigs C, Saenger W Sandhoff K (2006) Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant saposin A lacks lipid extraction capacity. J Biol Chem 281, 32451 32460.
40. Schägger H von Jagow G (1987) Tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368 379.
41. Honing S, Ricotta D, Krauss M, Spate K, Spolaore B, Motley A, Robinson M, Robinson C, Haucke V Owen DJ (2005) Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell 18, 519 531.
42. Cooper MA, Hansson A, Löfås S Williams DH (2000) A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal Biochem 277, 196 205.
43. Bitto E, Li M, Tikhonov AM, Schlossman ML Cho W (2000) Mechanism of annexin I-mediated membrane aggregation. Biochemistry 39, 13469 13477.
44. Stahelin RV Cho W (2001) Roles of calcium ions in the membrane binding of C2 domains. Biochem J 359, 679 685.
45. Stremmel W Debuch H (1976) Bis(monoacylglycero)phosphate - a marker lipid of secondary lysosomes? Hoppe Seylers Z Physiol Chem 357, 803 810.
46. Fischer G Jatzkewitz H (1975) The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe Seylers Z Physiol Chem 356, 605 613.
47. Amidon B, Brown A Waite M (1996) Transacylase and phospholipases in the synthesis of bis(monoacylglycero)phosphate. Biochemistry 35, 13995 14002.
48. Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T Popp M (1989) Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr 149, 31 39.
49. Alattia JR, Shaw JE, Yip CM Prive GG (2006) Direct visualization of saposin remodelling of lipid bilayers. J Mol Biol 362, 943 953.
50. Wilkening G, Linke T, Uhlhorn-Dierks G Sandhoff K (2000) Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. J Biol Chem 275, 35814 35819.
51. Stinshoff K Jatzkewitz H (1975) Comparison of the cerebroside sulphatase and the arylsulphatase activity of human sulphatase A in the absence of activators. Biochim Biophys Acta 377, 126 138.
52. Schuette CG, Pierstorff B, Huettler S Sandhoff K (2001) Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis. Glycobiology 11, 81R 90R.
53. Morimoto S, Kishimoto Y, Tomich J, Weiler S, Ohashi T, Barranger JA, Kretz KA O'Brien JS (1990) Interaction of saposins, acidic lipids, and glucosylceramidase. J Biol Chem 265, 1933 1937.
54. Vaccaro AM, Ciaffoni F, Tatti M, Salvioli R, Barca A, Tognozzi D Scerch C (1995) pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J Biol Chem 270, 30576 30580.
55. Vaccaro AM, Tatti M, Ciaffoni F, Salvioli R, Barca A Roncaioli P (1993) Studies on glucosylceramidase binding to phosphatidylserine liposomes: the role of bilayer curvature. Biochim Biophys Acta 1149, 55 62.
56. Vaccaro AM, Tatti M, Ciaffoni F, Salvioli R, Maras B Barca A (1993) Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes. FEBS Lett 336, 159 162.
57. Bleistein J, Heidrich HG Debuch H (1980) The phospholipids of liver lysosomes from untreated rats. Hoppe Seylers Z Physiol Chem 361, 595 597.
58. Matsuzawa Y Hostetler KY (1979) Degradation of bis(monoacylglycero) phosphate by an acid phosphodiesterase in rat liver lysosomes. J Biol Chem 254, 5997 6001.
59. Patterson MC, Vanier MT, Suzuki K, Morris JA, Carstea E, Neufeld EB, Blanchette-Mackie JE Pentchev PG (2001) Niemann-Pick disease type C: a lipid trafficking disorder. In The Metabolic and Molecular Bases of Inherited Disease (Scriver CR, Beaudet AL, Sly WS Valle D, eds), Vol. 3, pp. 3611 3633. McGraw-Hill, New York.
60. Harzer K, Massenkeil G Fröhlich E (2003) Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non-neurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disorders. FEBS Lett 537, 177 181.
61. Cheruku SR, Xu Z, Dutia R, Lobel P Storch J (2006) Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J Biol Chem 281, 31594 31604.
62. Babalola JO, Wendeler M, Breiden B, Arenz C, Schwarzmann G, Locatelli-Hoops S Sandhoff K (2007) Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein. Biol Chem in press.
63. Artelt P, Morelle C, Ausmeier M, Fitzek M Hauser H (1988) Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68, 213 219.
64. Henseler M, Klein A, Glombitza GJ, Suziki K Sandhoff K (1996) Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system. J Biol Chem 271, 8416 8423.
65. Hoffman CS (1997) Rapid isolation of yeast chromosomal DNA. In Current Protocols (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA Struhl K, eds), pp. 13.112 13.11.4. Wiley, New York.
66. Klein A, Henseler M, Klein C, Suzuki K, Harzer K Sandhoff K (1994) Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo. Biochem Biophys Res Commun 200, 1440 1448.
67. Packer NH, Lawson MA, Jardine DR Redmond JW (1998) A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J 15, 737 747.
68. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76 85.
69. Zschoche A, Fürst W, Schwarzmann G Sandhoff K (1994) Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. Eur J Biochem 222, 83 90.
70. MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK Hu LR (1991) Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim Biophys Acta 1061, 297 303.
71. Cooper MA, Try AC, Carroll J, Ellar DJ Williams DH (1998) Surface plasmon resonance analysis at a supported lipid monolayer. Biochim Biophys Acta 1373, 101 111.
72. Stenberg E, Persson B, Roos H Urbaniczky C (1991) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J Colloid Interface Sci 143, 513 526.